3P Targeting Pancreatic Adenocarcinoma Upregulated Factor (PAUF) to Treat Pancreatic Cancer (PC): in Vivo Efficacy and Safety of PBP1510, a First in Class Monoclonal Antibody (Mab)

IN VIVO EFFICACY AND SAFETY OF PBP1510, A FIRST IN CLASS MONOCLONAL ANTIBODY (mAb) Sumita Pradhan1, Sang Seok Koh1,2, Yeon Jeong Kim1,2, Jin Park3, Seong-Yun Jeong3, Kedar Diwakar Mandakhalikar1, Jamie Kim1, Litha Jaison1 1Prestige Biopharma Limited, Biopolis, Singapore 138567; 2Department of Biological Sciences, Dong-A University, Busan 49315, South Korea; 3Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, South Korea Poster 3P Abstract 216